Pages that link to "Q34003436"
Jump to navigation
Jump to search
The following pages link to Comparing predictors of conversion and decline in mild cognitive impairment (Q34003436):
Displaying 50 items.
- 18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) (Q24186399) (← links)
- Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's Disease (Q26744646) (← links)
- Is MRI better than CT for detecting a vascular component to dementia? A systematic review and meta-analysis (Q26851523) (← links)
- Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic Criteria (Q26864063) (← links)
- Brain imaging in Alzheimer disease (Q26996299) (← links)
- The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception (Q27006831) (← links)
- Clinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkers (Q27008249) (← links)
- Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatments (Q27024117) (← links)
- Genetic markers in biological fluids for aging-related major neurocognitive disorder (Q27027348) (← links)
- Alliance for aging research AD biomarkers work group: structural MRI. (Q27692607) (← links)
- The Alzheimer's disease neuroimaging initiative: progress report and future plans (Q28749585) (← links)
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers (Q29620245) (← links)
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria (Q30458193) (← links)
- Impaired long distance functional connectivity and weighted network architecture in Alzheimer's disease (Q30596643) (← links)
- Bi-level multi-source learning for heterogeneous block-wise missing data (Q30663979) (← links)
- Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings (Q30666527) (← links)
- A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative (Q30724134) (← links)
- Neurodegenerative disease diagnosis using incomplete multi-modality data via matrix shrinkage and completion (Q30746157) (← links)
- Extension and refinement of the predictive value of different classes of markers in ADNI: four-year follow-up data (Q30773959) (← links)
- What have novel imaging techniques revealed about metabolism in the aging brain? (Q30850844) (← links)
- Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease (Q30871982) (← links)
- 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception (Q30971403) (← links)
- Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2 (Q30981669) (← links)
- Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review (Q31096423) (← links)
- Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction (Q31121286) (← links)
- Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation (Q33573761) (← links)
- Neuropsychological Testing and Machine Learning Distinguish Alzheimer's Disease from Other Causes for Cognitive Impairment (Q33599831) (← links)
- Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database (Q33604453) (← links)
- Estrogen: a master regulator of bioenergetic systems in the brain and body (Q33623924) (← links)
- Enhanced glutamate uptake into synaptic vesicles fueled by vesicle-generated ATP from phosphoenolpyruvate and ADP. Proposed role of a novel enzyme (Q33630877) (← links)
- Clinical impact of updated diagnostic and research criteria for Alzheimer's disease (Q33640939) (← links)
- Conversion Discriminative Analysis on Mild Cognitive Impairment Using Multiple Cortical Features from MR Images (Q33701135) (← links)
- Disease progression model for Clinical Dementia Rating-Sum of Boxes in mild cognitive impairment and Alzheimer's subjects from the Alzheimer's Disease Neuroimaging Initiative (Q33726385) (← links)
- Quantitative structural MRI for early detection of Alzheimer’s disease (Q33729033) (← links)
- Alzheimer’s Disease: Implications of the Updated Diagnostic and Research Criteria (Q33797240) (← links)
- Amyloid burden, neuronal function, and cognitive decline in middle-aged adults at risk for Alzheimer's disease (Q33920450) (← links)
- Detection of early Alzheimer's disease in MCI patients by the combination of MMSE and an episodic memory test (Q33942367) (← links)
- Recent advances in imaging Alzheimer's disease. (Q33946440) (← links)
- Everyday episodic memory in amnestic mild cognitive impairment: a preliminary investigation (Q33982038) (← links)
- A point-based tool to predict conversion from mild cognitive impairment to probable Alzheimer's disease (Q33990078) (← links)
- The spectrum of cognitive impairment in Lewy body diseases (Q34019751) (← links)
- Multi-method analysis of MRI images in early diagnostics of Alzheimer's disease (Q34055598) (← links)
- The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. (Q34065449) (← links)
- Brain imaging in the study of Alzheimer's disease (Q34102331) (← links)
- Mild Cognitive Impairment: Baseline and Longitudinal Structural MR Imaging Measures Improve Predictive Prognosis (Q34176310) (← links)
- Task force on Alzheimer's disease trial methodology: recruitment and retention, data management and analysis. The use of imaging in recruitment: maintenance and methodological issues in Alzheimer's trials (Q34231481) (← links)
- Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment (Q34231888) (← links)
- Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set (Q34311058) (← links)
- Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions (Q34318022) (← links)
- Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies (Q34384006) (← links)